Perioral dermatitis - I-Perioral Dermatitis
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Iipapule ezijikeleze umlomo kunye neempumlo ezinobubomvu obungasemva zihlala zijongwa ngendlela yepetshi okanye ipustule ejikeleze umlomo.
References
Perioral dermatitis yimeko yesikhumba enobungozi edla ngokubonwa kwabasetyhini abancinci, ebonakala ngamaqhuma amancinci abomvu okanye amabala omileyo, amaxolo esikhumba emlonyeni. Nangona ichaphazela indawo ejikeleze umlomo, inokuvela kufuphi namehlo kunye neempumlo, ekhokelela kwisidlaliso sayo, i-periorificial dermatitis. Ukusetyenziswa kwe-topical steroids ebusweni kunokubangela le meko, ngoko ke inyathelo lokuqala kunyango lidla ngokuyeka ukusetyenziswa kwezi steroids. Olunye unyango olunokukhethwa luquka ukusebenzisa i-topical metronidazole okanye i-calcineurin inhibitors, okanye ukuthatha i-tetracycline antibiotics. I-Perioral dermatitis idla ngokuphendula kakuhle kunyango, kodwa ngamanye amaxesha inokuqhubeka okanye ibuyele ngokuphindaphindiweyo.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Ipropolis yimveliso ye-lipophilic ethathwe kwizityalo ngeenyosi. Injongo yale ngxelo yetyala yayikukubonisa ukubaluleka kwale nto njengonobangela wokuchasana ne-cheilitis. Isigulana esineminyaka engama-21 ubudala sakhalaza nge-pruritic perioral eczema iminyaka emi-5. Kwiinyanga ezidlulileyo nayo ichaphazele intamo. Emva kokuxilongwa kwe-dermatitis yoqhagamshelwano, wangeniswa kuvavanyo lwe-patch. Isiphumo sovavanyo lwe-patch saqinisekisa ngamandla kwipropolis (++) .
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Izifo ezahlukeneyo zesikhumba ezivuthayo ezibonakaliswa ngamapule erythematous. Isifo esixhaphakileyo ngokonyango - folliculitis, rosacea ; Xa kuthelekiswa isifo esinqabileyo - eosinophilic pustular folliculitis (EPF) , granulomatous periorificial dermatitis (GPD) , lupus miliaris disseminatus faciei (LMDF) .
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
I-Topical steroids inokuba ngunobangela wale meko kwaye izinto zokuthambisa kunye nezithambiso nazo zinokuba negalelo kuphuhliso lwesifo solusu. Unyango luqhelekile ngokumisa i-topical steroids kunye nezithambiso, kwaye kwiimeko ezinzima kakhulu, ukuthatha i-tetracyclines ngomlomo. Ukuyeka i-steroids kunokubangela ukuba irhashalala ibe mandundu.
Imeko iqikelelwa ukuba ichaphazele i-0.5-1% yabantu ngonyaka kwihlabathi eliphuhlileyo. Ukuya kuthi ga kwi-90% yabachaphazelekayo ngabasetyhini abaphakathi kweminyaka eyi-16 kunye ne-45 iminyaka.
○ Unyango ― OTC Amachiza
I-Perioral dermatitis idla ngokubangelwa yi-dermatitis engapheliyo ye-cosmetics, ngoko ke ukusebenzisa izimonyo emlonyeni akukhuthazwa. Ukuthatha i-OTC antihistamine kunokuba luncedo. Unyango lwaludla ngokufuneka kwiinyanga ezininzi.
#OTC antihistamine